Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform


Out of Business LATEST DEAL TYPE

Operator of a technology platform intended to facilitate the discovery of biomarkers. The company's technology platform is into identifying biomarkers for non-invasive diagnosis of breast cancer using biochemical analysis of blood samples, enabling clients to classify disease-specific biomarkers and target for drug discovery in human diseases and also apply it in the field of animal science.

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 120 Albany Street, Tower II
  • Suite 850
  • New Brunswick, NJ 08901
  • United States

+1 (732) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore CellXplore’s full profile, request a free trial.

CellXplore Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Sep-2018 00000 Completed Out of Business
1. Early Stage VC 01-Oct-2007 00000 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »